Compounds > sucrose

sucrose and atorvastatin

sucrose has been researched along with atorvastatin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Funatsu, T; Kakuta, H; Miyata, K; Takasu, T1
Funatsu, T; Kakuta, H; Miyata, K; Noguchi, M; Suzuki, M; Takasu, T1
Castro, AA; Lapa, FR; Matheus, FC; Prediger, RD; Santos, AR; Tasca, CI; Viola, GG; Wiemes, BP1
Abd Elmaaboud, MA; Albarraq, AA; Kabel, AM1
Babu, PP; Kapadia, B; Mandaliya, D; Misra, P; Muggalla, CS; Patel, S; Prajapati, B; Rapaka, N; Saxena, U; Seshadri, S1

Other Studies

6 other study(ies) available for sucrose and atorvastatin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    European journal of pharmacology, 2002, Nov-29, Volume: 455, Issue:2-3

    Topics: Animals; Apolipoproteins B; Atorvastatin; Benzimidazoles; Carrier Proteins; Cholesterol; Fatty Acids; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Oxidation-Reduction; Pyrroles; Rats; Rats, Sprague-Dawley; Sucrose; Triglycerides

2002
Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.
    Metabolism: clinical and experimental, 2003, Volume: 52, Issue:5

    Topics: Animals; Area Under Curve; Atorvastatin; Dietary Fats; Emulsions; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Lipoproteins; Lipoproteins, VLDL; Male; Olive Oil; Plant Oils; Postprandial Period; Pyrroles; Rats; Rats, Sprague-Dawley; Sucrose; Triglycerides

2003
Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
    Brain research, 2013, Jun-04, Volume: 1513

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Analysis of Variance; Animals; Antiparkinson Agents; Atorvastatin; Brain; Cognition Disorders; Cytokines; Disease Models, Animal; Food Preferences; Heptanoic Acids; Male; Maze Learning; Mood Disorders; Motor Activity; Parkinsonian Disorders; Pyrroles; Rats; Rats, Wistar; Social Behavior; Sucrose; Sweetening Agents; Swimming; Tyrosine 3-Monooxygenase

2013
Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
    Prostaglandins, leukotrienes, and essential fatty acids, 2015, Volume: 96

    Topics: Animals; Atorvastatin; Body Weight; Cytokines; Diet, High-Fat; Disease Models, Animal; Fatty Acids, Omega-3; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats, Wistar; Sucrose

2015
Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model.
    Scientific reports, 2019, 06-19, Volume: 9, Issue:1

    Topics: Animals; Atorvastatin; Diet; Disease Models, Animal; Fatty Acids; Feeding Behavior; Gene Expression Regulation; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Insulin; Muscles; Rats; Signal Transduction; Simvastatin; Sucrose

2019